Collaboration
Amicus Seals $430M Financing from Blackstone Post-Pompe Disease Drug Approval
Fresh from securing FDA approval for its combination treatment targeting Pompe disease, Amicus Therapeutics has attracted a significant investment. Amicus ...
Samsung Biologics expands antibody production deal with Bristol Myers Squibb for $242 million
Samsung Biologics, a leading biopharmaceutical contract manufacturing organization, has strengthened its partnership with Bristol Myers Squibb (BMS) by securing a ...
Phesi partners with Krystelis to boost diversity in clinical trials
Clinical research and analytics specialist Phesi, in collaboration with Krystelis, has introduced a groundbreaking service aimed at enhancing the diversity ...
Nurix and Seagen Join Forces to Pioneer Cancer Therapies by Combining Protein Degradation and ADC Technologies
Seagen has just sealed a strategic partnership with Nurix Therapeutics, headquartered in San Francisco. This collaboration is poised to unlock ...
Chiesi Teams Up with Aliada to Advance Brain-Penetrating Therapies for Central Nervous System Disorders
Chiesi Pharma, a specialist in rare diseases, has entered into a strategic collaboration with US biotech company Aliada Therapeutics. The ...
To increase treatment and adherence rates for children with HIV in low- and middle-income countries, Gilead collaborates with CHAI and Penta
Source – Gilead Sciences Gilead Sciences is pleased to announce two collaborative initiatives. The first initiative aims to expedite the ...
LifeArc’s project for rare diseases will spend £100 million on patient care
Source – LifeArc LifeArc, a self-funded non-profit medical research organization and charity, has announced the launch of the Rare Disease ...
Sanofi teams up with local pharma firms for vaccine production in Saudi Arabia
Following recent developments by AstraZeneca and National Resilience in the United Arab Emirates, Sanofi has emerged as the next major ...
